cjc-1295 and ipamorelin stack ghk cu cjc 1295 safety mots c Current research stack: CJC-1295/Ipamorelin Tirzepatide, CJC‑1295/Ipamorelin | Metabolic Reset

Generally, fat in the diet should not make up more than 30% of total calories, and 10% of those calories should not originate from saturated fat

In terms of documented efficacy, this is not a close comparison: GLP-1 S has shown weight reductions in the range of 13-20% of body weight in clinical trials, while AOD-9604s pivotal trial failed to demonstrate a significant effect at that scale

Harris, K

Previously, a Phase 2 randomized trial of an older, less potent GLP-1 drug, Liraglutide in 200 participants, was presented at the 2024 Alzheimers Association annual conference but has not yet been published

Body composition (DEXA or similar) only useful with a long enough window to detect change

Do not apply to sensitive skin types or apply very sparingly (highly diluted) to avoid excess irritation